{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:48:31Z","timestamp":1794631711803,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2021\/09431-0"],"award-info":[{"award-number":["2021\/09431-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Cutaneous melanoma can lead to metastasis, and it is associated with high mortality. Currently, there are no widely accepted immunohistochemistry markers for melanoma prognosis in routine staging. Preferentially expressed antigen in melanoma (PRAME) is a possible biomarker for prognosis in several noncutaneous neoplasms. Ki-67 is a cell proliferation marker correlated with poor outcomes in many cancers. This study assessed PRAME and Ki-67 as potential prognostic markers for sentinel lymph node outcomes and survival among melanoma patients. This is a retrospective study analyzing cutaneous melanoma cases from a Brazilian cancer center (2005\u20132021). All cases were tested using immunohistochemistry to evaluate PRAME expression and Ki-67 index. Descriptive analysis, Spearman correlations, means comparison, Kaplan\u2013Meier analysis, \u03c7<jats:sup>2<\/jats:sup>, and Cox models were performed. In univariate analysis of 123 cutaneous melanoma cases, high extent (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0267) and elevated intensity (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.043) of PRAME were associated with decreased overall survival. The Ki-67 index was associated with overall survival (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.05) and sentinel lymph node status (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0403), with a positive correlation between the markers (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0004) and between Ki-67 and Breslow thickness (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0001). However, in multivariate analysis, only Breslow thickness significantly influenced overall survival (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0003). Then, the present results can suggest that elevated PRAME and Ki-67 expression are associated with poor overall survival in cutaneous melanoma; however, in multivariate analysis, only the Breslow thickness had a significant influence. These findings highlight the potential of PRAME and Ki-67 as prognostic markers, opening frontiers that could improve strategies for treating cutaneous melanoma.<\/jats:p>","DOI":"10.1097\/dad.0000000000002863","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T14:00:35Z","timestamp":1729087235000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Marcel Arakaki","family":"Asato","sequence":"first","affiliation":[{"name":"School of Medicine, The Federal University of Mato Grosso do Sul, Campo Grande, Brazil;"},{"name":"School of Medicine, S\u00e3o Paulo State University, Botucatu, SP, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Alves","family":"Moraes Neto","sequence":"additional","affiliation":[{"name":"Amaral Carvalho Hospital, Ja\u00fa, SP, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Padovani de Toledo","family":"Moraes","sequence":"additional","affiliation":[{"name":"School of Medicine, S\u00e3o Paulo State University, Botucatu, SP, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Polizel","family":"Ocanha-Xavier","sequence":"additional","affiliation":[{"name":"School of Medicine, S\u00e3o Paulo State University, Botucatu, SP, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Carlos","family":"Takita","sequence":"additional","affiliation":[{"name":"School of Medicine, The Federal University of Mato Grosso do Sul, Campo Grande, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell A.","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California Davis School of Medicine, Sacramento, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela Esther Alencar","family":"Marques","sequence":"additional","affiliation":[{"name":"School of Medicine, S\u00e3o Paulo State University, Botucatu, SP, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-419X","authenticated-orcid":false,"given":"Jos\u00e9 C\u00e2ndido Caldeira","family":"Xavier-J\u00fanior","sequence":"additional","affiliation":[{"name":"School of Medicine, S\u00e3o Paulo State University, Botucatu, SP, Brazil;"},{"name":"School of Medicine, Centro Universit\u00e1rio Unisalesiano Auxilium, Ara\u00e7atuba, SP, Brazil; and"},{"name":"Pathology Institute of Ara\u00e7atuba, Ara\u00e7atuba, SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"key":"R1-20241211","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3390\/cancers12092508","article-title":"Insights into differentiation of melanocytes from human stem cells and their relevance for melanoma treatment","volume":"12","author":"Mirea","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R5-20241211","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.pas.0000213262.61855.7d","article-title":"Prognostic significance of extent of ulceration in primary cutaneous melanoma","volume":"30","author":"Grande Sarpa","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R6-20241211","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1177\/000313481107700816","article-title":"Lymphovascular invasion as a prognostic factor in melanoma","volume":"77","author":"Egger","year":"2011","journal-title":"Am Surg"},{"key":"R7-20241211","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"R8-20241211","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/labinvest.2017.8","article-title":"Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance","volume":"97","author":"Aung","year":"2017","journal-title":"Lab Invest"},{"key":"R9-20241211","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41379-020-0500-9","article-title":"The prognostic significance of microsatellites in cutaneous melanoma","volume":"33","author":"Niebling","year":"2020","journal-title":"Mod Pathol"},{"key":"R10-20241211","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database","volume":"29","author":"Thompson","year":"2011","journal-title":"J Clin Oncol"},{"key":"R11-20241211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1590\/abd1806-4841.20186690","article-title":"Melanoma: clinical, evolutive and histopathological characteristics of a series of 136 cases","volume":"93","author":"Ocanha-Xavier","year":"2018","journal-title":"An Bras Dermatol"},{"key":"R12-20241211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5858\/arpa.2014-0075-RA","article-title":"Immunohistochemistry in dermatopathology","volume":"139","author":"Ferringer","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20241211","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20241211","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cancers11070984","article-title":"Cancer testis antigens and immunotherapy: where do we stand in the targeting of PRAME?","volume":"11","author":"Al-Khadairi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R15-20241211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-007-9643-3","article-title":"Prevalence and prognostic and predictive relevance of PRAME in breast cancer","volume":"109","author":"Doolan","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R16-20241211","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bbrc.2012.02.110","article-title":"Expression and prognostic relevance of PRAME in primary osteosarcoma","volume":"419","author":"Tan","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20241211","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.oraloncology.2012.08.005","article-title":"PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions","volume":"49","author":"Szczepa\u0144ski","year":"2013","journal-title":"Oral Oncol"},{"key":"R18-20241211","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R19-20241211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12967-018-1757-3","article-title":"PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer","volume":"17","author":"Al-Khadairi","year":"2019","journal-title":"J Transl Med"},{"key":"R20-20241211","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"R21-20241211","doi-asserted-by":"crossref","first-page":"882","DOI":"10.12659\/MSM.892807","article-title":"The prognostic role of Ki-67\/MIB-1 in cervical cancer: a systematic review with meta-analysis","volume":"21","author":"Pan","year":"2015","journal-title":"Med Sci Monit"},{"key":"R22-20241211","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I\/II melanoma","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"R23-20241211","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000002125","article-title":"PRAME expression is a useful tool in the diagnosis of primary and metastatic dedifferentiated and undifferentiated melanoma","volume":"47","author":"Hornick","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R24-20241211","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/cup.14495","article-title":"PRAME expression in cutaneous melanoma does not correlate with disease\u2010specific survival","volume":"50","author":"Parra","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R25-20241211","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.3390\/cancers13153864","article-title":"Diffuse PRAME expression is highly specific for thin melanomas in the distinction from severely dysplastic nevi but does not distinguish metastasizing from non-metastasizing thin melanomas","volume":"13","author":"Gassenmaier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R26-20241211","doi-asserted-by":"crossref","first-page":"154915","DOI":"10.1016\/j.prp.2023.154915","article-title":"PRAME expression in 137 primary cutaneous melanomas and comparison with 38 related metastases","volume":"251","author":"Bello","year":"2023","journal-title":"Pathol Res Pract"},{"key":"R27-20241211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.11.002","article-title":"Preferentially expressed antigen in melanoma immunohistochemistry as an adjunct for differential diagnosis in acral lentiginous melanoma and acral nevi","volume":"120","author":"Hu","year":"2022","journal-title":"Hum Pathol"},{"key":"R28-20241211","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.pathol.2022.05.012","article-title":"Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics","volume":"54","author":"Rawson","year":"2022","journal-title":"Pathology"},{"key":"R29-20241211","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/mjd.2000.109282","article-title":"Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma","volume":"43","author":"Henrique","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R30-20241211","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAI.0000000000000530","article-title":"Expression of Ki-67 and estrogen receptor beta in primary cutaneous melanoma as a potential indicator of regional lymph node positivity","volume":"27","author":"Udovi\u010di\u0107-Gagula","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:00:41Z","timestamp":1733958041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002863","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}